Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Hamilton Neuros™ Syringe for Neuroscience Research
Thursday, March 22, 2012
Maximizes precision and minimizes injection site damage.

Brazil Scientific Police Advance Drug Testing Facilities
Monday, March 12, 2012
Randox Toxicology Evidence machine adopted by Brazi Police Force.

Connecting the World of Microfluidics
Friday, March 02, 2012
Dolomite’s Multiflux® connectors and interfaces prove extremely popular.

Intelligently Dose Chemical Reactors at High Flow Rates with the Atlas Syringe Pump
Thursday, March 01, 2012
This innovative pump, which is extremely chemically resistant, allows automated volumetric dosing from 100 µl/min to 200 ml/min, providing ultimate flexibility for automated chemistry applications.

The Gold Standard for HTS Microplate Readers, the PHERAstar FS, Shines at SLAS2012
Wednesday, February 29, 2012
BMG LABTECH showcases novel microplate readers.

Microfluidic Expert Dolomite Looks Back on Successful Year 2011
Tuesday, February 07, 2012
The company has had continued growth in 2011 with the launch of over 15 new products.

A New MEMS-based Paradigm for Liquid Flow Management
Tuesday, January 31, 2012
Measure viscosity with 20µl (microliter) samples.

UV-Vis Microvolume Spectrophotometer
Thursday, January 19, 2012
Thermo Fisher Scientific Inc. introduces the NanoDrop Lite, a compact, personal UV-Vis microvolume spectrophotometer that complements full-featured NanoDrop 2000/2000c and NanoDrop 8000 instruments.

Microsaic Systems Launches New Website and Technical Support Portal
Thursday, January 19, 2012
The company has launched its new, easy to use, interactive website, designed to provide an invaluable source of scientific and technical information on the use and applications of the the Microsaic 3500 MiD®.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 1043
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed